Skip to content

H2020HORIZON

Mybiotech GmbH

Country
DEGermany
Defence projects
0
Projects, all programmes
15
As coordinator
1
EU contribution (CORDIS)
EUR 8,748,186
Active
2017 to 2025

Projects

15 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
MEDiCSAnticancer approach based on the Metabolic Disruption of Cancer Stem Cells with high effectivity across a wide range of solid tumoursHORIZON2025ParticipantEUR 773,398
VIVIDClinical Validation of In Vivo Imaging for Detecting Immune DynamicsHORIZON2025ParticipantEUR 380,813
GreenX3Innovative and sustainable materials, processes and technologies for a GREENer and circular economyHORIZON2023CoordinatorEUR 521,078
NABIHEALANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALINGHORIZON2023ParticipantEUR 352,750
POTENTIALPlatform Optimisation To Enable NanomaTerIAL safety assessment for rapid commercialisationHORIZON2023ParticipantEUR 193,550
ETERNALBoosting the reduction of the environmental impact of pharmaceutical products throughout their entire life cycle.HORIZON2022ParticipantEUR 423,312
Bio2BrainNose-to-Brain Delivery of Biopharmaceutics for the therapy of central nervous system diseases: A design-based approach for efficient drug delivery systemsH20202021ParticipantEUR 252,788
PhoenixPharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative ProductsH20202021ParticipantEUR 4,229,247
CompSafeNanoNanoInformatics Approaches for Safe-by-Design NanoMaterialsH20202021ParticipantEUR 46,000
NanoCarbGlyco-Nanoparticles for Applications in Advance NanomedicineH20202018PartnerEUR 0
NANOSTEMNew nanomaterials for neural stem cells drug deliveryH20202018ParticipantEUR 249,216
iFermenteriFERMENTER - CONVERSION OF FORESTRY SUGAR RESIDUAL STREAMS TO ANTIMICROBIAL PROTEINS BY INTELLIGENT FERMENTATIONH20202018ParticipantEUR 128,025
N2B-patchNose to Brain Delivery of Antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical DeviceH20202017ParticipantEUR 559,138
npSCOPEThe nanoparticle-scope : a new integrated instrument for accurate and reproducible physico-chemical characterisation of nanoparticles (npSCOPE)H20202017ParticipantEUR 202,000
nTRACKMultimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regenerationH20202017ParticipantEUR 436,871

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.